You may be familiar with the drug ketamine – a psychedelic club drug sometimes called Special K – as a party drug that’s been around for decades. It’s also an anesthetic used in hospitals, burn centers, and veterinary medicine. For almost ten years, though, various studies have popped up reporting ketamine’s potential for treating severe depression. The American Psychiatric Association is now moving toward more thorough research and endorsement of ketamine to treat depression that is severe enough to be considered treatment-resistant.
Thus far, studies are showing that ketamine produces an antidepressent effect in a quick fashion, and also ends suicidal thinking almost immediately. Comparing this to traditional forms of treatment that take weeks or months to take effect, ketamine might be a great option for individuals suffering from severe depression and suicidal thoughts. Continued research should prove more on the topic.
Click here to read the full article by Sara Solovitch for the Washington Post.